Table 3. Impact of pulmonary TB on developing COPD in sensitivity analyses.
Study population | p value | Hazard ratio (95% CI) |
All subjects | <0.001 | 2.054 (1.768–2.387) |
Cases of follow-up duration >2 years | <0.001 | 1.565 (1.249–1.960) |
Cases of follow-up duration >3 years | 0.003 | 1.577 (1.163–2.139) |
Cases of follow-up duration >4 years | 0.008 | 1.780 (1.160–2.731) |
Cases of follow-up duration >5 years | <0.001 | 3.641 (2.024–6.550) |
Cases of follow-up duration >6 years | 0.008 | 3.361 (1.372–8.239) |
Age ≤40 years | <0.001 | 4.291 (2.623–7.020) |
Age >40 years | <0.001 | 1.937 (1.653–2.269) |
Age >50 years | <0.001 | 1.836 (1.553–2.169) |
Age >60 years | <0.001 | 1.684 (1.400–2.026) |
Age >70 years | <0.001 | 1.607 (1.261–2.049) |
Women | <0.001 | 2.473 (1.782–3.433) |
Men | <0.001 | 1.975 (1.669–2.337) |
Abbreviations: COPD, chronic obstructive pulmonary disease; TB, tuberculosis.